Bacteriophages in autoimmune disease and other inflammatory conditions
Section snippets
The role of microbes in the aetiology of autoimmune disease and other inflammatory conditions
There are several autoimmune diseases and other inflammatory conditions where an infectious aetiology is suggested by the epidemiology, clinical course and pathological findings. It is now generally accepted that commensal bacteria play a role in the pathogenesis of inflammatory bowel disease [1], [2], [3]. Experimental data have shown that HLA-B27 transgenic rats spontaneously develop colitis and arthritis, however when they are bred in a germ-free environment, no or attenuated inflammation
Structure and genetics of bacteriophages
Bacteriophages, often referred to simply as phages, are viruses that infect bacteria. They are relatively simple structures and consist of nucleic acid contained within a protein coat. As in conventional viruses, the nucleic acid may be either DNA or RNA but not both. The protein coat or capsid is constructed from a large number of subunits or capsomeres. These capsomeres may be made up of single subunits or groups of subunits and are organised either helically to form a hollow tube as seen in
Hypothesis
My hypothesis is that bacteriophages may play a role as antigens in the pathogenesis of autoimmune disease and inflammatory conditions. Candidate diseases that could be explained by the hypothesis are inflammatory bowel disease, rheumatoid arthritis, ankylosing spondylitis and other connective tissue disorders such as SLE, as well as multiple sclerosis, atherosclerosis and Kawasaki disease.
Lytic phages may be acquired when new bacteria carrying phages are introduced into the normal flora. Lytic
Published data supporting the hypothesis
A recent study has demonstrated that patients with abdominal aortic aneurysm are more likely to have been infected with strains of Chlamydia pneumoniae that harbour phages rather than strains without phages [28]. The phage-containing strains were identified by the detection in the patients’ sera of antibodies against phage capsid. The authors speculated whether the phage containing strains of C. pneumoniae are more virulent presumably by phage conversion, but no genes for a putative virulence
Testing the hypothesis
The hypothesis is testable but there may be difficulties. Panels of phage antigen could be screened against sera from patients with candidate inflammatory or autoimmune conditions, or screened for induction of T-cell proliferation or for their ability to act as superantigens. The difficulty would be choosing which of the potentially hundreds of phages might be likely candidates. If molecular mimicry is the mechanism, the number of likely phages could be narrowed down by comparison of host and
Conclusion
The hypothesis accounts for why bacteria have been implicated in the aetiology of some autoimmune and inflammatory conditions and why no proof of a pathogenic role for these bacteria has been proven. The hypothesis describes how bacteria may act as vectors for the actual aetiological agents, bacteriophages. The bacteriophages may cause disease as new antigens arriving with new bacteria, or be revealed as new antigens following induction in lysogenic organisms within the normal bacterial flora.
References (35)
- et al.
Bacteria as the cause of ulcerative colitis
Gut
(2001) - et al.
Clinical aspects and pathophysiology of inflammatory bowel disease
Clin Microbiol Rev
(2002) Inflammatory bowel disease
N Eng J Med
(2002)- et al.
The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats
J. Exp. Med.
(1994) - et al.
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice
Infect. Immun.
(2001) - et al.
Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
Clin. Exp. Immunol.
(1995) Properties of strains of Escherichia coli isolated from the faeces of patients with ulcerative colitis, patients with diarrhoea and normal persons
J. Pathol. Bacteriol.
(1968)- et al.
Ulcerative colitis and Escherichia coli with adhesive properties
J. Clin. Pathol.
(1988) - et al.
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial
Lancet
(1999) - et al.
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial
Gastroenterology
(2000)
Microbial DNA in the synovium – a role in aetiology or a mere bystander
Lancet
Somatic serogroups, capsular types, and species of faecal Klebsiella in patients with ankylosing spondylitis
J. Clin. Microbiol.
Etiology of sarcoidosis
Sarcoidosis
Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of japanese patients with sarcoidosis
Lancet
Bacterial infection as a cause of multiple sclerosis
Lancet
Infection as a cause of multiple sclerosis
BMJ
Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies
Clin Microbiol Rev
Cited by (18)
Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches
2017, Gastroenterology Clinics of North AmericaCitation Excerpt :Therapeutic deployment of bacteriophage therapy in IBD has used naturally occurring or genetically engineered viral parasites.327 Of interest, it is now proposed that phages could exert immunogenic effects,333 with several studies demonstrating direct effects of intestinal phages on the immune system, including proinflammatory and anti-inflammatory responses.318,334–343 Research exploring bacteriophage therapy remains in its early stages; however, the prospective that natural or engineered phages (ie, augmented antibacterial capability) can intimately control microbial population structure, while mediating mucosal immunity offers an intriguing prospect in the management of IBD patients.
The gut feeling during the COVID-19 pandemic
2023, Sustainable Health and the COVID-19 Crisis: Interdisciplinary PerspectivesIdentification of key genes and pathways associated with Crohn's disease by bioinformatics analysis
2019, Scandinavian Journal of Gastroenterology